Israel-Cannabis (iCAN), a leading Israeli developer of medical cannabis formulations, clinical trials and cannabis testing, has formed a joint venture with LeafCann Research and Advisory, a leader in the development of cannabis medications, clinical research and education, based in Melbourne, Australia.
The new venture, iCAN: Australia, will collaborate on a range of initiatives including medicinal cannabis research, education, acceleration, and innovation.
This joint venture is a significant step in the collaborative efforts between Israel and Australia in this field, combining Israel’s role as the world’s medical cannabis R&D powerhouse with Australia’s newly eased access regulations for patients in need.
Read more here.
Israel Trade and Economic Commission in Sydney, Australia 